MARKET

CSCIF

CSCIF

Cosciens Biopharma
OTCPK
2.090
+0.030
+1.46%
Closed 11:46 12/05 EST
OPEN
2.090
PREV CLOSE
2.060
HIGH
2.090
LOW
2.090
VOLUME
59
TURNOVER
123
52 WEEK HIGH
4.605
52 WEEK LOW
1.960
MARKET CAP
6.65M
P/E (TTM)
-0.3478
1D
5D
1M
3M
1Y
5Y
1D
COSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia
TipRanks · 6d ago
COSCIENS Biopharma Signs 10-Year Exclusive Distribution Deal With Wuzhou For Macrilen In Hong Kong, Macao, Singapore, Guangdong, And Hainan, Including Minimum Initial Order Of €800,000
Benzinga · 6d ago
Weekly Report: what happened at CSCIF last week (1124-1128)?
Weekly Report · 6d ago
Weekly Report: what happened at CSCIF last week (1117-1121)?
Weekly Report · 11/24 09:13
Weekly Report: what happened at CSCIF last week (1110-1114)?
Weekly Report · 11/17 09:12
COSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts
TipRanks · 11/14 22:49
COSCIENS Biopharma appoints interim CEO
Seeking Alpha · 11/14 22:27
COSCIENS Biopharma Reports Q3 2025 Financial Results
TipRanks · 11/13 04:42
More
About CSCIF
COSCIENS Biopharma Inc. is a Canada-based life science company. The Company is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The Company's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Webull offers COSCIENS Biopharma Inc (USA) stock information, including OTCPK: CSCIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCIF stock methods without spending real money on the virtual paper trading platform.